Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:CSCI - Post by User

Post by prophetoffactzon Sep 25, 2024 7:40pm
151 Views
Post# 36241270

Perplexity Ai: New President and CEO:

Perplexity Ai: New President and CEO:Based on the information provided, I don't have any specific details about Cosciens or their CEO search process. However, I can provide some general insights on executive searches for companies of this nature, considering Ronnie Miller's involvement as Chairman and Board member:

CEO Search Process and Timeline

The search for a new President and CEO typically takes around 3-6 months for established companies, though it can vary depending on several factors:
  • The urgency of the replacement
  • The complexity of the role and company
  • The availability of qualified candidates
  • The thoroughness of the search and interview process
Given Ronnie Miller's extensive experience in the pharmaceutical industry, particularly his 22-year tenure as President and CEO of Roche Canada, his involvement as Chairman likely adds credibility and expertise to the search process. This could potentially expedite the timeline or attract high-caliber candidates.

Credibility of Potential Candidates

The credibility of the likely replacement will depend on several factors:

Industry Experience: Given Ronnie Miller's background, the search may focus on candidates with significant experience in the pharmaceutical or biotechnology sectors.

Leadership Track Record: Candidates with proven success in executive roles at comparable companies will be viewed as more credible.

Strategic Vision: The ability to articulate a clear vision for the company's future will be crucial.

Cultural Fit: Alignment with the company's values and culture, which may be influenced by Ronnie Miller's leadership philosophy, will be important. 

Ronnie Miller's reputation and network in the industry could potentially attract high-caliber candidates. His experience in mentoring top talent and fostering innovation suggests he may place a strong emphasis on finding a leader who can drive growth and innovation for Cosciens. While the specific details of Cosciens' search are not available, the involvement of an experienced industry leader like Ronnie Miller as Chairman and Board member likely adds significant value to the process and increases the chances of finding a credible and capable new President and CEO.
<< Previous
Bullboard Posts
Next >>